March 19, 2021

Get Irked - Investments in Play - March 19, 2021

Click above image for larger version

The Week’s Biggest Winner & Loser

Logitech (LOGI)

In a rough week for stocks, Logitech was able to finish in the green and squeak out a +2.61% gain, earning itself the Week’s Biggest Winner.

Square (SQ)

Always the most volatile asset in the group, Square (SQ) got slammed this week, dropping -7.13% and earning itself the spot of the Week’s Biggest Loser.

Portfolio Allocation

Click charts for enlarged versions



Target Position Size

Get Irked - Investments in Play - Current Holdings - March 12, 2021et Irked's Pandemic Portfolio Holdings as of March 19, 2021

Click above image for larger version

Portfolio Breakdown

Get Irked - Year-to-Date Performance - Investments in Play vs. Speculation in Play - 2020 Year-to-Date Performance

Click above image for larger version

Year-to-Date Performance

Current Position Performance

Square (SQ)


1st Buy 8/5/2016 @ $11.10
Current Per-Share: (-$131.60)*

Logitech (LOGI)


1st Buy 11/11/2016 @ $24.20
Current Per-Share: (-$2.29)*

Boeing (BA)


1st Buy 2/14/2012 @ $79.58
Current Per-Share: (-$333.52)*

Apple (AAPL)


1st Buy 4/18/2013 @ $14.17
Current Per-Share: (-$45.02)*

Tesla (TSLA)


1st Buy 3/12/2020 @ $111.30
Current Per-Share: (-$140.53)*

Nike (NKE)


1st Buy 2/14/2012 @ $26.71
Current Per-Share: (-$29.85)*

Nvidia (NVDA)


1st Buy 9/6/2016 @ $63.10
Current Per-Share:  (-$102.76)*



1st Buy 7/26/2017 @ $167.29
Current Per-Share: (-$32.76)*

Canopy (CGC)


1st Buy 5/24/2018 @ $29.53
Current Per-Share: -($0.38)*

Disney (DIS)


1st Buy 2/14/2012 @ $41.70
Current Per-Share: (-$2.00)*

Amazon (AMZN)


1st Buy 2/6/2018 @ $1,382.96
Current Per-Share: -($4,999.10)*

Twilio (TWLO)


1st Buy 8/8/2019 @ $125.71
Current Per-Share: (-$16.25)*

GW Pharm (GWPH)


1st Buy 7/25/2018 @ $142.28
Current Per-Share: (-$1.20)*

Take Two (TTWO)


1st Buy 10/9/2018 @ $128.40
Current Per-Share: -($19.95)*

Skyworks (SWKS)


1st Buy 1/31/2020 @ $113.60
Current Per-Share: $79.04

JP Morgan (JPM)


1st Buy 10/26/2017 @ $102.30
Current Per-Share: $75.60



1st Buy 11/6/2018 @ $120.87
Current Per-Share: $69.80

Salesforce (CRM)


1st Buy 6/11/2018 @ $134.05
Current Per-Share: $115.20

Dow (DOW)


1st Buy 5/13/2019 @ $53.18
Current Per-Share: $35.26

Berkshire (BRK.B)


1st Buy 8/2/2019 @ $199.96
Current Per-Share: $142.22

* Indicates a position where the capital investment was sold.
Profit % for * positions = Total Profit / Starting Capital Investment

A negative share price indicates the dollar amount of profit for each share currently held.

This Week’s Moves

Apple (AAPL): Added to Position

Apple (AAPL) once again took it on the chin this week, leading me to add even more to my position when it dipped below $120 briefly on Friday, adding shares at $119.89.

From here, my next buy target is $104.90, slightly above the next point of support based on previous selloffs. As for a sell target, I’m holding Apple until it exceeds the 7.14% allocation for the portfolio, making my next sell price around $200-$205 per share.

AAPL closed the week at $119.99, up +$0.10 from where I added Friday.

Dow Chemical (DOW): Dividend Reinvestment

Dow Chemical (DOW) paid out its ample quarterly dividend of $0.70 a share on March 15, an annual yield of 4.42% at its $63.37 closing price.

I use my broker’s Dividend Reinvestment Program (DRiP) to receive fractional shares instead of cash, both lowering my per-share cost -1.09% from $35.65 to $35.26 and also increasing my allocation, allowing for compounding interest over time.

DOW is in the sweet spot of the reopening right now as an expected infrastructure bill would definitely increase business for the company, however, in the meantime, its dividend is definitely worth keeping it in the portfolio.

From here my next buy target is $59.50 and I have no plans to reduce the position until it exceeds the 7.14% target allocation for the portfolio.

IDEXX Laboratories (IDXX): Added to Position

On Thursday, IDEXX Laboratories (IDXX) sold off with the rest of the tech, nearing its low from the last tech wreck. Given that IDEXX Labs is more of a play on the humanization of pets than it is a play on technology, I decided to add some to my position with an order that filled at $490.48, -14.55% off IDXX’s all-time high of $573.99.

The order raised my per-share “cost” from -$32.76 to -$25.25 meaning each share in the position costs nothing and, in fact, adds $25.25 to the overall portfolio’s value.

From here, my next buy target is $426.00 and I currently don’t have a sell target for this position until it exceeds the allocation size for the portfolio.

IDXX closed the week at $484.88, down -1.14% from where I added Thursday.

JP Morgan Chase (JPM): Profit-Taking

While banks perform exceptionally well in a rising interest rate environment like we have here, when JP Morgan (JPM) broke through to new all-time highs on Thursday, I decided to take some profits with an order that filled at $161.17.

The order locks in +67.36% in profits on shares I bought during the pandemic crash for $96.30 on March 11. The sale also lowered my per-share cost -7.58% from $81.80 to $75.60. From here, my next buy target is $119.70 and my next sell target is around $180.

JPM closed the week at $155.14, down -3.74% from where I sold Thursday.

Want Further Clarification?

As always, if you have questions about any of my positions or have positions of your own that you’re curious about – feel free to leave a comment below!

See you next week!

Don't get mad, Get Irked and learn how to invest for yourself!


Get Irked is a small community made up of helpful, friendly and motivated investors and traders of all levels looking to reach the same goal – the ability to invest profitably in order to achieve financial independence.

Investors of ALL experience levels are welcome.

Join Get Irked by clicking here!

Disclaimer: Eric “Irk” Jacobson and all other Get Irked contributors are not investment or financial advisers. All strategies, trading ideas, and other information presented comes from non-professional, amateur investors and traders sharing techniques and ideas for general information purposes. As always, all individuals should consult their financial advisers to determine if an investing idea is right for them. All investing comes with levels of risk with some ideas and strategies carrying more risk than others. As an individual investor, you are accountable for assessing all risk to determine if the strategy or idea fits with your investment style. All information on Get Irked is presented for educational and informational purposes only.